<code id='F897A489A3'></code><style id='F897A489A3'></style>
    • <acronym id='F897A489A3'></acronym>
      <center id='F897A489A3'><center id='F897A489A3'><tfoot id='F897A489A3'></tfoot></center><abbr id='F897A489A3'><dir id='F897A489A3'><tfoot id='F897A489A3'></tfoot><noframes id='F897A489A3'>

    • <optgroup id='F897A489A3'><strike id='F897A489A3'><sup id='F897A489A3'></sup></strike><code id='F897A489A3'></code></optgroup>
        1. <b id='F897A489A3'><label id='F897A489A3'><select id='F897A489A3'><dt id='F897A489A3'><span id='F897A489A3'></span></dt></select></label></b><u id='F897A489A3'></u>
          <i id='F897A489A3'><strike id='F897A489A3'><tt id='F897A489A3'><pre id='F897A489A3'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:89
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Listen: Vivek Ramaswamy's star turn & leaky drug data
          Listen: Vivek Ramaswamy's star turn & leaky drug data

          Doesbiotechprepareyouforthepresidency?WhoreallywantstoguttheFDA?AndwhydodrugcompaniesstrugglewithIT?

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo